Ethema Health 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Ethema Health in the fourth quarter 2025?
Due to the lack of equity, it was not possible to calculate Ethema Health Corporation 's return on equity (ROE) in its fourth quarter 2025

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-2	-1	-3	-2	-2
Return On Equity (TTM)	-	-	-	-	-
GRST's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-10	-9	-9	-8	-7
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to GRST Management Effectiveness >> GRST's 5 Years Annual ROE >> Compare GRST ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

GRST Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	-10	-7	-6	-9	-10
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-2	-2	1	0	-2
Y / Y Net Income Change	-	-	571.47 %	-	-
Return On Equity	-	-	-	-	-

Back to GRST Management Effectiveness >> GRST's 5 Years Annual ROE >> Compare GRST ROE to its Competitors

Annual Roe Comment

Despite deterioration in net income, company improved ROE to in 2025, company improved ROE to 571.47 % compared to the prior year.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GRST's' Return on Equity at Yahoo Finance
GRST's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GRST's Competitors
Subscribers only: Roe for Ethema Health 's Suppliers
Subscribers only: Return On Equity for GRST's Customers

Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector	ROE
Enlivex Therapeutics Ltd	63.85 %
Dariohealth Corp	59.48 %
Nrc Health	58.51 %
Zoetis Inc	56.31 %
Alpha Tau Medical Ltd	55.29 %
Transmedics Group Inc	53.88 %
Pulmatrix Inc	53.50 %
Abeona Therapeutics Inc	53.18 %
Novo Nordisk A	52.79 %
Medinotec Inc	52.76 %
Concentra Group Holdings Parent Inc	47.62 %
Theravance Biopharma inc	46.03 %
Galmed Pharmaceuticals Ltd	43.72 %
Acadia Pharmaceuticals Inc	41.90 %
Arrowhead Pharmaceuticals Inc	41.16 %
Gilead Sciences Inc	41.14 %
Tenet Healthcare Corp	40.89 %
Agilent Technologies inc	40.80 %
Gsk Plc	39.41 %
Bristol myers Squibb Company	39.17 %
Hutchmed china Limited	36.98 %
Oramed Pharmaceuticals Inc	36.81 %
Solventum Corporation	36.74 %
Newgenivf Group Limited	36.53 %
Merck and Co Inc	36.16 %
Adma Biologics Inc	34.98 %
Illumina Inc	34.94 %
Compugen Ltd	34.40 %
Vaxart Inc	33.83 %
Johnson and Johnson	33.78 %

Date modified: 2026-09-19T05:12:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.